Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product

Nature Immunology

Volumn 2, Issue 8, 2001, Pages 681-690

  Latour, Sylvain ^a,b,c   Gish, Gerald ^d   Helgason, Cheryl D ^e   Humphries, R Keith ^e   Pawson, Tony ^d   Veillette, André ^a,b,f  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d MOUNT SINAI HOSPITAL   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD150 ANTIGEN; CELL PROTEIN; CELL RECEPTOR; CYTOKINE; CYTOPLASM PROTEIN; GENE PRODUCT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INOSITOL; PHOSPHATASE; PROTEIN DOK1; PROTEIN DOK2; PROTEIN FYNT; PROTEIN INHIBITOR; PROTEIN SHC; PROTEIN TYROSINE KINASE; RAS PROTEIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOID CELL LINE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; ONCOGENE SRC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKED DISORDER;

ANIMALS; ANTIGENS, CD; CARRIER PROTEINS; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MICE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0034889004     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/90615     Document Type: Article

References (46)

1. X-linked lymphoproliferative disease: a progressive immunodeficiency
2. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein
3. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
4. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
5. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
6. H2 cells
7. A novel receptor involved in T cell activation
8. Signaling lymphocytic activation molecule (CDw 150) is homophilic but self-associates with very low affinity
9. H2 cells
10. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-γ production
11. Potential pathways for regulation of NK and T cell responses: Differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4
12. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
13. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
14. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
15. 2B4: An NK cell activating receptor with unique specificity and signal transduction mechanism
16. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
17. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2DIA
18. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
19. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis
20. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling
21. dok is a mediator of inhibitory FcγRIIB signals in B cells
22. p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction
23. Identification of the Abl- and rasGAP-associated 62 kD protein as a docking protein, Dok
24. p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
25. dok-2 defines a new family of RasGAP-binding proteins
26. Targeted disruption of SHIP leads to hematopoietic perturbations, lung pathology, and a shortened life span
27. Expression of a novel form of the fyn proto-oncogene in hematopoietic cells
28. fyn
29. The Src and Csk families of tyrosine protein kinases in hematopoietic cells
30. fyn mutant mice display differential signaling in thymocytes and peripheral T cells
31. Signal transduction by lymphocyte antigen receptors
32. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling
33. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling
34. Tec kinases: A family with multiple roles in immunity
35. H2 cytokines
36. Induction of NF-κB by the Akt/PKB kinase
37. The roles of CD4 and CD8 in T cell activation
38. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLII fusion gene
39. lck
40. Regulation of T cell antigen receptor signaling by Syk tyrosine protein kinase
41. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac
42. Identification of a monoclonal antibody specific for a murine T3 polypeptide
43. Evidence implicating L3T4 in class II MHC antigen reactivity; Monoclonal antibody GK 1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocytes lines
44. lck
45. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site
46. lck with phosphotyrosine-containing proteins